Strontium ranelate shows no added benefit in fracture healing for wrist fractures .
This report has been verified
by one or more authors of the
original publication.
Strontium ranelate as an adjuvant for fracture healing: clinical, radiological, and ultrasound findings in a randomized controlled study on wrist fractures
Osteoporos Int. 2016 Jan;27(1):211-8.40 patients with wrist fractures were treated with antiosteoporotic therapy (calcium and vitamin D) with or without the addition of strontium ranelate. The purpose of this study was the investigate the proposed clinical advantages and increased functional recovery of the addition of strontium ranelate by recording bone callus formation, cortical continuity, and permanence of fracture gap (via ultrasonographic confirmation). Results demonstrated that the addition of strontium ranelate provided no advantageous clinical or functional recovery benefits as evidenced by comparable outcome measures to the control group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
